Sarepta Therapeutics | Lånekapital



Loan Capital Ändra Datum
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Daiichi Sankyo JPY 101.03B 95M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Incyte USD 33.54M 5.32M 2024-12
Insmed USD 1.13B 147.77M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Moderna USD 39M 586M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 57.4B 597M 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Tectonic Therapeutic USD 387K 126K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Sarepta Therapeutics Lånekapital - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.